C-myc Internal Ribosome Entry Site (IRES)

From WikiMD's Food, Medicine & Wellness Encyclopedia

C-myc Internal Ribosome Entry Site (IRES) is a crucial regulatory element located within the 5' untranslated region (5' UTR) of the c-myc oncogene mRNA. This element enables the ribosome to initiate protein synthesis directly at the start codon of the c-myc mRNA, bypassing the need for the traditional cap-dependent translation initiation mechanism. The c-myc gene encodes a transcription factor that plays a pivotal role in cell cycle progression, apoptosis, and cellular transformation, making its expression tightly regulated and of significant interest in the study of cancer and cell biology.

Function[edit | edit source]

The C-myc IRES facilitates a cap-independent translation initiation mechanism, allowing for the synthesis of the c-Myc protein under conditions where cap-dependent translation is inhibited, such as during cell stress, mitosis, and in response to various growth factors. This alternative translation initiation pathway ensures the continuous production of c-Myc, a protein essential for cell proliferation and growth, even under adverse conditions.

Structure[edit | edit source]

The structure of the C-myc IRES is complex and not fully understood. It is known to contain several secondary structural elements, such as stem-loops, that are crucial for its IRES activity. These structures are thought to interact with specific ribosomal proteins and IRES trans-acting factors (ITAFs) to facilitate the recruitment of the ribosome to the mRNA.

Regulation[edit | edit source]

The activity of the C-myc IRES is regulated by multiple factors, including the availability of ITAFs and the phosphorylation state of certain proteins involved in the translation initiation process. Changes in cellular conditions, such as nutrient availability and stress signals, can also modulate IRES activity, thereby affecting c-Myc protein levels.

Clinical Significance[edit | edit source]

Given its role in promoting cell proliferation and survival, the C-myc IRES is a potential target for therapeutic intervention in various cancers. Inhibiting IRES-mediated c-Myc translation could provide a means to suppress tumor growth and proliferation. Research into small molecules and antisense oligonucleotides that can specifically inhibit the C-myc IRES activity is ongoing, with the aim of developing novel anti-cancer therapies.

Research Tools[edit | edit source]

Studying the C-myc IRES involves a range of molecular biology techniques, including RNA structure analysis, reporter assays for measuring IRES activity, and the use of genetic engineering tools to manipulate IRES elements within the c-myc mRNA. These tools are essential for elucidating the mechanisms of IRES function and its regulation under physiological and pathological conditions.

This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD